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Abstract 
Defect-based testing is a powerful tool for finding errors in software. Many software manu-
facturers avoid this method because it requires a detailed defect taxonomy that is expensive to 
construct and difficult to validate. The Association for the Advancement of Medical Instru-
mentation (AAMI) is developing SW91
1
, a defect taxonomy to be published as a standard for 
health software. This paper details three methods to validate SW91 for its comprehensiveness. 
The initial validations of SW91 were conducted via mapping vulnerabilities from the Com-
mon Weakness Enumeration and a dataset from a medical device software development com-
pany in Ireland. Taxonomy based testing is another validation method proposed in this re-
search and its applicability was investigated using empirical data from a medical device soft-
ware development company in Ireland. Finally, the paper details future plans to implement 
taxonomy based testing to improve software quality in medical device software and to 
validate SW91. This validation will focus on the efficiency, reliability, ability to perform use-
ful analyses and defect coverage of SW91. 
Keywords 
Defect taxonomy, Defect Classification scheme for health software, Validation, Tax-
onomy based testing, Testing  
1. Introduction 
This paper is an extension of the EuroSPI 2017 conference paper: Benefits of Defect Tax-
onomies and Validation of a new Defect Classification for Health Software [1]. Medical de-
vices increasingly rely on software to provide functionality [2]. Due to the introduction of 
advanced technologies, the medical device software industry is facing massive growth of 
complex software [2]. This massive growth of medical device software leads to quality risks. 
Table 1 shows the number of adverse events related to medical device software failures be-
tween 2006 and 2011. 
                                                     
1
 This document is still under study and subject to change.   
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The US Food and Drug Administration (FDA) reports that from 2005 to 2011, 19.4% of 
medical device recalls were related to software [3]. Another study focused on recalls of medi-
cal devices related to computer-based failures such as software, hardware, inputs, outputs, or 
battery issues. This study reported that 2,303,441 recalls out of 12,024,836 were related to 
software. Software issues accounted for 33.3% of class I recalls, 65.6% of class II recalls and 
75.3% of class III recalls [4], [5]. The Food and Drug Administration (FDA) recall process 
includes specifically identifying software-related recalls in order to improve medical device 
quality and to ensure patient safety [6]. 
The increasing complexity and the growth of medical device software make it difficult to 
control and prevent defects. Medical device software defects have resulted in increasing FDA 
recalls and they have potentially increased the risk of patient injuries including threats to life 
[7], [8]. In order to find software defects and to ensure software quality, software quality as-
surance practices have been integrated into software development. Software quality assurance 
processes aim to minimise software defects and show that software meets requirements. There 
are several software quality assurance activities, such as testing and inspections, which can be 
used to validate software [9]. However, medical device software development companies face 
challenges in improving software quality such as the inability to specify the software re-
quirements properly, the lack of adequate software quality assurance procedures and the lack 
of relevant metrics to track software quality [10], [11]. 
Research studies suggest that a defect taxonomy is the best way to prevent and control de-
fects [12]–[14]. Defect taxonomies were successfully used in various ways during the testing 
phase of software development, such as in system testing, brainstorming sessions for testers, 
measuring testing efficiency and classifying defects [14]–[18]. People use customised or orig-
inal defect taxonomies in different domains such as the safety critical domain, the business 
domain and the telecommunications domain. Before they use defect taxonomies, they validate 
their defect taxonomies in terms of reliability, efficiency, and completeness [17], [19]–[21]. 
This paper explains the benefits of defect taxonomies, the development of a new defect 
taxonomy for health software called SW91 by AAMI and how this research contributed to the 
validation of SW91. Three different validation methods are proposed from his research in-
cluding a new testing approach call taxonomy based testing. This paper is structured as fol-
lows: Section 2 explains what a defect taxonomy is and how industries have used defect tax-
onomies during software development. Section 3 explains the benefits of using defect taxon-
omies. Section 4 explains the development of new defect taxonomy for health software, 
SW91 and it briefly details the structure of SW91. Section 5 explains three different valida-
tion methods proposed from this research to validate SW91. It includes mapping defects from 
databases, mapping defects from medical device software development companies and a test-
ing approach call taxonomy based testing which details how defect categories from a taxono-
my can be used in testing. Section 6 outlines plans for future research and it details how tax-
onomy based testing will be used to validate SW91 and to improve software quality in medi-
cal device software development. Section 7 presents the summary and conclusions. 
2. State of the art – The use of defect taxonomies in industry 
A defect taxonomy is a system of hierarchical categories designed to be a useful aid for 
reproducibly classifying defects in the software development lifecycle [22]. There are many 
other terms for defect taxonomies including fault categorisation, defect classification, fault 
classification scheme and bug taxonomy. In this paper, the terms defect taxonomy and defect 
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classification scheme are used interchangeably. Table 2 lists a number of defect taxonomies 
which are widely used in different software domains [23], [24]. 
The remainder of this section explains how different industries have used various defect 
taxonomies for a variety of purposes in different phases of the software development lifecycle 
in order to improve software quality. 
In 1998, at the Motorola Corporate Software Centre, the GSM Products Division’s Base 
Station Systems (GSMBSS) conducted a study on how the orthogonal defect classification 
(ODC) scheme can be used to measure the progress of software development [25]. The ODC 
scheme was applied to an existing project with data collected by Fagan inspection [9]. After a 
successful feasibility study to verify the suitability of the ODC scheme, the team mapped de-
fect data with minor modifications into the ODC scheme. This study proved that software 
development progress measurement and process improvement feedback can be produced from 
data which was collected using an existing inspection method by adopting the ODC scheme. 
The authors of this study believed the ODC scheme can easily be applied to enhance software 
quality and to improve customer satisfaction while developing defect prevention and qualita-
tive process management techniques [25]. 
In 2004, Lutz and Mikulski [19] published work on the analysis of 199 anomalies from 
seven spacecraft at the Jet Propulsion Laboratory. The purpose of this study was to improve 
the safety of future missions. The ODC scheme was selected to classify the post-launch safety 
critical software anomalies in order to extract the defect signature. The following outcomes 
were highlighted from this study: 
• Training on documentation of anomalies can limit the reoccurrence of anomalies.  
• The benefit of maintaining the documentation of system requirements for the opera-
tional process has been identified. 
• Anomalies’ analysis enhances the reusability of knowledge from one system to anoth-
er. 
• When comparing the outcomes from other methods related to operational risk, the 
anomaly patterns obtained by classifying the anomalies using the ODC scheme pro-
vided additional understanding of operational risks. 
Finally, the authors of this study stated classifying anomalies led to understanding the anoma-
lies triggers and contributed to preventing operational anomalies.  
Freimut et al. [20] conducted a study at Robert Bosch GmbH in the business unit for Gas-
oline Systems (GS) and published their work in 2005. Gasoline Systems developed electronic 
control units for gasoline engines with embedded software as a key component. It was decid-
ed to apply quantitative data management techniques in quality assurance strategies to 
overcome the lack of information related to quality assurance and overall system quality at 
Bosch GS. They defined, introduced and validated their customised defect classification 
scheme to track defects which are involved in software development and process measure-
ment [20]. The following outcomes were obtained after applying their defect classification 
scheme: 
• Defect flow distribution and its outputs were observed. 
• Identification of the defects introduced in early stages and identified in later stages. 
• Defect data from the case study which identified categories with a high number of de-
fects. 
• Providing the measurement outputs to management. 
In 2007, Robillard et al. [26] published work detailing the measurable test efficiency in a 
software product due to changing testing practices. This research was conducted with a team 
that developed audio software for video games. Two different testing phases, A and B, were 
used to measure the test efficiency. Phase A used implicit testing practices to record defects. 
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In the second phase, B, an “Easy to follow” scheme was proposed to record the testing prac-
tices in order to make developers aware of the type of testing activities involved. A modified 
ODC scheme was used to record the defects in both testing phases and the following out-
comes were observed [26]:  
• The distribution of defects for the type of activity conducted in each phase, such as de-
sign review, code inspection, and unit test. 
• The distribution of defects based on the discovery attributes. Discover attributes indi-
cate who found the defects. 
• The distribution of defects based on the activity qualifier attributes. The activity quali-
fier attribute indicates whether defects were found opportunistically or during planned 
testing. 
• The statistical understanding of software process measurement using both types of 
testing. 
In 2008, the ODC scheme was used in NASA flight projects. The ODC scheme was used 
as an extension of the COnstructive QUALity Model (COQUALMO) developed by Raymond 
Madachy and Barry Boehm from the University of Southern California, USA. The ODC 
COQUALMO model was used for critical NASA flight projects [18]. The ODC scheme was 
successfully adopted in defect reduction strategies. The ODC COQUALMO model helped in 
providing a highly detailed view of the defect profiles and their impact on specific risks. The 
ODC COQUALMO model with automated risk minimisation helped to meet the quality goals 
of NASA’s flight projects in a shorter time with fewer resources [18]. 
In 2010, Li et al. [17] presented an extended and modified defect classification scheme 
named the Orthogonal Defect Classification scheme for Black-box Defects (ODC-BD) which 
was created based on the ODC scheme. This empirical study was aimed at helping black-box 
defect analysers and black-box testers to improve their testing efficiency and analysis. It was 
proved that the effort for defect analysis was reduced by 15% after applying the ODC-BD 
scheme. The test efficiency, measured as the number of detected defects per unit time, in the 
first week, without using the ODC-BD scheme, was 0.075. In the second month, the test effi-
ciency increased to 0.125 using the ODC-BD scheme [17]. This empirical study with 1660 
black-box defects is a good example of measuring the black-box testing process with the 
ODC scheme. 
In 2012, Mellegård et al. [27] published their work on developing an effective and sys-
tematic software defect classification scheme at Volvo car corporation in Sweden. They de-
veloped a software defect classification scheme “the Light-weight Defect Classification 
scheme”, which complements the IEEE standard classification for software anomalies [28], 
[29]. This study demonstrated the customisation of a generic defect classification scheme to 
classify defects. Adopting a customised defect classification scheme minimised the time re-
quired to find defects while helping to characterise the defects. The Hewlett-Packard defect 
categorisation scheme has been used within Hewlett-Packard departments for many different 
purposes such as root cause analysis and defect presentation [23], [30]. 
In 2014, Nuno Silva and Marco Vieira [31] published their work which demonstrated the 
importance of domain specific defect classification schemes. They focused on four systems 
from the aerospace and space industries. They demonstrated the following problems in adopt-
ing a generic classification scheme into a safety critical domain: 
• There are problems with adopting a generic defect classification scheme without con-
sidering the defect propagation effects and the interconnection of defects from differ-
ent phases of the software development lifecycle. 
• Inability to cover all the defects with existing listed defect types, defect triggers and 
defect impacts. 
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• Differentiating dimensions to keep the orthogonality of the defects was not easy to 
achieve. 
• Not showing the connection to the quality models. 
• There were difficulties getting the necessary level of information related to each defect 
to map with the defect type, defect trigger or defect impact. 
• Difficulties mapping non-functional defects. 
• Difficulties mapping the defects to a related standard. 
The above points demonstrate the problems in adopting a generic defect classification 
scheme into a safety critical domain. This study highlights the need for improved and domain 
specific defect taxonomies to classify defects in safety critical domains. Since medical device 
software is often safety critical, the necessity of a domain specific defect classification 
scheme has been identified and a defect classification scheme is being developed for 
healthcare software called SW91 [32]. The development of SW91 is explained in Section 4. 
This section detailed how different defect classification schemes were used in different 
industries from 1998 to 2014 and the importance of domain specific defect classification 
schemes. The next section discusses the benefits of defect classification schemes. 
3. Benefits of defect classification schemes 
Bernd Freimut [23] has detailed various benefits of defect classification schemes includ-
ing characterisation of the defects found, defect prevention, control inspections, evaluation 
and improvement of technologies, control testing, plan testing and reduce field defects.  
Vallespir et al. [24] stated a defect classification scheme makes it easy to find the injected 
defects while providing information on phases, activities, and disciplines throughout the soft-
ware development lifecycle. Robert B. Grady from Hewlett Packard stated that the benefit of 
classifying defects is to help find the correct quality assurance activity. He stated: “As you 
categorise the defects, you will uncover a variety of symptoms. A typical first step will be for 
you to decide to do better or different inspections or tests” [30]. When combining both Val-
lespir et al. and Robert B. Grady’s statements, injected defects could be identified and classi-
fied by a defect classification scheme. Those classified defects will inform the choice of the 
correct quality assurance activities. Detailed defect classification schemes play a significant 
role in understanding the software development process [33]. Defect classification schemes 
can be created for several different purposes. These include: 
1. Making decisions during software development. 
2. Tracking defects for process improvement. 
3. Guiding the selection of test cases. 
4. Analysing research results [33]. 
Vogel has detailed a procedure for medical device software defect management. “Classifi-
cation” is the second of eight steps. Vogel’s defect procedure supports the need for defect 
classification schemes in medical device software development. He stated the importance of 
classification in medical device software as follows: “the classification is important for later 
determination on the recommendations and means for verifying any changes made to deal 
with the defect”. Safety critical domains have utilised defect classification schemes to reduce 
defects and to improve analysis [2], [18], [31]. Safety critical domains need a unique defect 
classification scheme tailored to their unique needs [31]. The medical device software indus-
try is such a safety critical domain and hence should have its own domain specific defect clas-
sification scheme. 
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The Association for the Advancement of Medical Instrumentation (AAMI) is developing 
a defect classification scheme for health software which includes medical device software. 
Section 4 explains the development of the defect classification scheme for health software 
called SW91. Before the development of SW91, there has been no defect classification 
scheme specifically developed for use in the medical device software industry. It is hoped that 
applying a defect classification scheme into the medical device software industry will bring 
similar benefits observed in Sections 2 and 3. 
4. AAMI and Development of SW91 
AAMI is a non-profit organisation founded in 1967 and it is the primary source of consen-
sus standards, both national and international, for the medical device industry, as well as prac-
tical information, support, and guidance for healthcare technology and sterilization profes-
sionals [34]. The development of SW91 started in 2014 and aims to provide a common lan-
guage to classify defects and improve software quality in health software including medical 
device software [32]. SW91 was published in September 2016 for first public comment. The 
comments were resolved and SW91 was published in April 2017 for second public comment. 
The comments on the second draft were resolved and currently, SW91 is in the final stage of 
processing to publish as a standard and will be published in Q2-Q3 2018.  
SW91 includes defect categories from the planning to the maintenance of a system. SW91 
contains multi-level defect categories at the parent level and child level. Each parent level 
defect category includes several child defect categories. Each defect category has a defect 
code with a unique number. This numbering system uses a hierarchical system.  
Table 3 shows the parent level defect categories from SW91. Each parent level category is 
numbered and each child level category is represented by appending a period and a number of 
the parent level number. Each defect category has annotations and some of the defect catego-
ries have an example as well. For example, Expression Evaluation (5.2.2.1) is one of the child 
level defect categories from Implementation Defects (5). It has the following annotation: 
“This category contains defects having to do with the way arithmetic, Boolean, string, and 
other expressions are evaluated.” 
SW91 contains annexes to demonstrate how to use SW91 defect categories and to show 
how user-friendly the standard is. For example, annex A of SW91 details how SW91 defect 
categories can be used in industries and academia. The following use cases are detailed in 
annex A:  
• Development organisation looking to remove common defects. 
• Development organisation performing an industry comparison. 
• Business manager measuring return on investment. 
• College professor studying software defect trends over time. 
From the literature review conducted as part of this research it was observed that defect 
taxonomies were validated for their reliability, usability, defect coverage and completeness. 
Since SW91 is a new defect taxonomy, it is important to validate SW91 before it is used. This 
research has identified three validation methods which are detailed in the following section.  
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5. Validation of SW91 
Bernd Freimut analysed different defect classification schemes based on their structure 
and their usability [23]. In the literature, it was found that defect classification schemes were 
validated for their reliability, ability to perform useful analyses, and efficiency [17], [19]–
[21]. These features will be considered in the validation of SW91. In addition to the above 
terms, the defect coverage of SW91 will be validated in this research. Validation of SW91 has 
the following three different tracks:  
1. Taxonomy based testing. 
2. Mapping defects from medical device software companies. 
3. Mapping defects from databases. 
Section 5.1 explains the first track of the validation using taxonomy based testing. Section 
5.2 explains the second track of validation and it details how data from a medical device 
software development company from Ireland was mapped to SW91 and how this mapping 
helped to conduct a retrospective analysis using a taxonomy based testing approach. Section 
5.3 presents the third track of validation and it explains how open source defect data was 
mapped into SW91. 
5.1 Taxonomy Based Testing 
Defect taxonomies have been successfully used in software testing [15]. Creating the test 
cases for the defect categories from a defect taxonomy gives better test coverage [15], [35]. 
Michael Felderer and Armin Beer have conducted significant research on defect taxonomy-
supported testing [14]. They stated, “Defect taxonomies can be applied to control the design 
of tests and the quality of releases to keep testing manageable although time and resources in 
projects are limited”. In their research, a novel process of system testing using a defect taxon-
omy has been proposed and implemented. A case study was used to explain how a defect tax-
onomy can be integrated into the standardised test process defined by the International Soft-
ware Testing Qualifications Board - ISTQB.  
In taxonomy based testing, the requirements will be mapped into potential defect catego-
ries from the defect taxonomy and the test cases will be written based on the requirements and 
the mapped defect categories. The test cases will be executed to verify whether the software 
complies with the relevant requirements and does not contain the mapped defect categories 
from the defect taxonomy. Figure 1 explains taxonomy based testing. Taxonomy based test-
ing will be used to validate SW91 in terms of the reliability, efficiency, useful analyses and 
the defect coverage. When it comes to the reliability of SW91, if a statistically significant 
number of quality assurance engineers at a medical device software company mapped the 
same given defects with the same defect categories from SW91, and then this will be used to 
demonstrate the reliability of SW91. At the end of the taxonomy based testing, if SW91 
helped to increase the test efficiency and helped to reduce similar software defects in future 
phases, this will be considered as validation of SW91 in terms of efficiency and useful anal-
yses. If SW91 covers all identified defects from the requirements to the final system, this will 
be considered as a validation of defect coverage. Taxonomy based testing will be 
implemented at different companies including medical device software companies and a test-
ing company. Section 6 details how taxonomy based testing will be implemented at the com-
panies.  
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Since this research is related to medical device software development, it is important to 
consider medical device software development processes. Successful medical device software 
development processes are required to demonstrate compliance with a set of medical device 
standards and regulations [36]. In that respect, EN 62304:2006+A1:2015 is a standard for the 
medical device software development process and it details the medical device software de-
velopment processes that are required in order to build safe software. Annex C.4 of EN 
62304:2006+A1:2015 explains a V-model for programmable electrical medical system re-
quirements [37]. This V model includes the medical device software development lifecycle 
processes included in EN 62304:2006+A1:2015. Since SW91 has defect categories for each 
phase of the medical device software development process stated in EN 
62304:2006+A1:2015, it can be linked with each phase of medical device software develop-
ment process stated in the V model from Annex C.4 of EN 62304:2006+A1:2015. Figure 2 
explains the modified V model from Annex C.4 of EN 62304:2006+A1:2015 [37] and SW91 
defect categories. The grey colour V model shows the medical device software development 
phases and the red colour V model shows the SW91 defect categories.  
When considering the V model shown in Figure 2, it is possible to implement taxonomy 
based testing at any phase of medical device software development such as software require-
ment analysis or software implementation. Test cases can be created at any phase of medical 
device software development and they can be executed in each phase’s validation step. Sec-
tion 6 details how this approach will be implemented at different companies.  
This section explained the first track of SW91 validation. The next two sections explain 
two different mappings conducted in this study. Baldassarre et al. defined and followed a the-
oretical comparison process in their harmonisation process of ISO/IEC 9001:2000 and 
CMMI-DEV [38]. It has following steps: 
• Analysing the models. 
• Designing the mapping. 
• Carrying out the mapping.  
• Presenting outcomes. 
• Analysing results. 
The above steps were considered in this research and following mappings were carried out: 
• Mapping data from a medical device software company into SW91 defect catego-
ries. 
• Mapping Common Weakness Enumeration (CWE) vulnerabilities into SW91 de-
fect categories. 
5.2 Mapping data from a medical device software company into 
SW91 defect categories 
 Company A from Ireland develops medical device software applications. Company A 
was contacted and empirical data was requested to map to SW91 defect categories. The bene-
fits of defect taxonomies, the taxonomy based testing approach and the need for defect taxon-
omies in the medical device software industry were presented to the management of company 
A and data was requested. Relevant data was obtained from company A and the following 
data has been used in this mapping: 
1. Defects.  
2. Software Design Specification.  
3. User Requirement Documentation.   
4. Risks. 
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5. Testing Protocols. 
Figure 3 displays the mappings of data from company A into SW91 defect categories. In 
mapping A as shown in Figure 3, the defects from company A contained defect symptoms 
such as algorithm not working correctly and warning alerts not appearing. These symptoms 
were due to some defects in company A’s application. Those defect symptoms were mapped 
into possible defect categories from SW91. Eight distinct defect symptoms were mapped into 
twenty distinct SW91 defect categories. Some slight changes of wording were observed be-
tween the defect symptoms from company A and SW91 defect categories. For example, a 
defect symptom from company A was described as “Units not converting correctly”. This 
defect was mapped into the following SW91 defect category: Inappropriate Cast or Type 
Conversion (5.3.2.1.4). All defects were mapped into SW91 defect categories.  
In mapping B from Figure 3, control flow diagrams from the software design specification 
document were mapped into SW91 defect categories. The appendix of the software design 
specification document from company A has very detailed control flow diagrams for their 
applications.  
They describe the functionality of the application step by step. In this study, three differ-
ent control flow diagrams were selected and each state of the control flow diagrams was 
mapped into distinct SW91 defect categories. In this mapping, all elements from the control 
flow diagrams were mapped into nineteen SW91 defect categories from architectural defects, 
design defects and implementation defects. Since SW91 uses a hierarchical numbering system 
for defect categories, it was easy to jump into the relevant defect category at the appropriate 
level. For example, if a control flow diagram has the following step: “Count <1”, then search-
ing for a relevant defect category from the implementation defects is straightforward. The 
following defect categories were assigned to the above processing step “Count <1”: 
• Mixed Sign (5.3.2.7.1). 
• Use Before Check (5.3.2.6). 
• Invalid Path (5.2.1.2.6). 
• Operator (5.2.2.1.1). 
In mapping C of Figure 3, the user requirement documentation from company A contains 
forty-one requirements including functional and non-functional requirements. Out of forty-
one requirements from the user requirements documentation, thirty-nine were mapped into 
forty-three distinct SW91 defect categories. Two non-functional requirements were very gen-
eral and could not be mapped into any existing SW91 defect categories. For every other re-
quirement, the defect categories were selected from SW91 and mapped. Every requirement 
from the user requirement documentation has associated risks which have been assigned a 
priority. Since the requirements were already mapped into SW91 defect categories in map-
ping C, those SW91 defect categories used in mapping C were merged with the risks associat-
ed with their requirements. Despite the user requirements documentation and software design 
specification documents being prepared for the company’s own use, it was possible to map 
them into SW91 defect categories.  
A separate mapping of the testing protocols and SW91 defect categories was not 
performed because the testing protocols were already linked with the relevant software design 
specification and the user requirements from the user requirements document. The defect cat-
egories from SW91 used in both mapping B and C were directly linked with the respective 
testing protocols.  
As we discussed in Section 5, in terms of the validation of a defect classification scheme, 
the defects from company A were mapped into SW91 defect categories and this mapping 
helped to validate the defect coverage of SW91. The reliability of SW91 can be observed 
here. Normally, the reliability of a defect classification scheme is determined by the mapping 
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of the same defects by different people. If different people map the same defects with the 
same defect categories from a classification scheme, this shows that the defect classification 
scheme has good reliability. Here, the same defects from three different documents including 
user requirements documentation, control flow diagrams from the software design specifica-
tion document and defect symptoms from defect data mapped to the same categories in 
SW91. Due to the confidentiality of the data from company A, it is not possible to detail all 
the mappings here.  
The next section explains how this mapping was used in the retrospective analysis of tax-
onomy based testing and the benefits that were observed from applying taxonomy based test-
ing.  
5.2.1 A retrospective study on taxonomy based testing  
This mapping work was used in a retrospective study of taxonomy based testing. The first 
step of taxonomy based testing proposes to map the requirements into defect categories from 
a defect taxonomy. In this study, the requirements and the software design specification from 
company A were mapped into SW91 defect categories. Defect symptoms from company A 
were also mapped into SW91 defect categories to see if taxonomy based testing can be per-
formed using the empirical data from a medical device software development company. From 
the three mappings (A, B and C), the following three sets of common SW91 defect categories 
were observed: 
1. Ten common SW91 defect categories from mapping A and mapping B. 
2. Eleven common SW91 defect categories from mapping A and mapping C. 
3. Six common SW91 defect categories from mapping A, mapping B and mapping C. 
When the requirements have been gathered and company A does this mapping, it will en-
able them to see the possible defect categories for each requirement. This type of mapping 
also allows goal oriented test cases to be written, consistent with taxonomy based testing. 
These goal oriented test cases will be based on the requirements and the respective mapped 
defect categories from SW91. Execution of the generated goal oriented test cases will save 
time in finding defects when executing the test cases.  
Since company A has detailed control flow diagrams, mapping each stage of the control 
flow diagram into SW91 defect categories will help to minimise defects at the development 
phase. When we have the potential defect categories for every stage, developers can work to 
avoid those defects. Quality assurance engineers can run the test cases to find the mapped 
defect categories. This will minimise the time to find the defects and it will help to prevent 
defects at the earliest possible phase of software development. 
 Company A has risks for every requirement in their user requirement documentation. 
Those risks are prioritised by severity. If every requirement is mapped into defect categories 
from SW91, the risks can be used to prioritise which defects should be fixed first. This study 
also revealed the following benefits which are detailed in the following sections: 
1. Defect reporting at the testing phase. 
2. Defect minimisation. 
3. Risk minimization. 
5.2.1.1 Defect reporting at the testing phase 
Defect data from company A contained defect symptoms such as warning alerts not ap-
pearing. Those defect symptoms must be reported by a software quality assurance engineer at 
company A. According to the current format of the defect reporting at company A, the devel-
opers do not know which defects caused the reported defect symptoms such as warning alerts 
not appearing. When the developers attempt to fix the reported defect symptoms, it will be 
hard for them to fix due to the current defect reporting format which does not provide details 
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of the defects causing the symptoms. Therefore, those defect symptoms could appear again in 
the second round of testing due to some other defect of which the developers or the software 
quality assurance engineer were not aware. In this situation, the developers and software qual-
ity assurance engineers wasted their time addressing a poorly defined defect. This situation 
can be addressed at company A by mapping the defect symptoms into actual defects. For ex-
ample, in mapping A, the defect symptom warning alerts not appearing was mapped into the 
following SW91 defect categories: 
• Invalid Path (5.2.1.2.6). 
• Parameter Type (4.2.2.2). 
• Wrong Algorithm Selected (4.2.4). 
• Parameter Structure (4.2.2.3). 
• Use Before Check (5.3.2.6). 
• Bad Translation (5.1). 
The developer can be informed of the possible defects with SW91 defect categories which 
could cause the reported defect symptom, warning alerts not appearing. Developers can try to 
fix the reported defect symptoms by addressing the mapped SW91 defects categories for the 
failed test. This type of mapping will minimise the reoccurrence of defect symptoms by 
checking all possible mapped SW91 defect categories. This type of mapping would reduce the 
development time and help to anticipate possible defects. If this mapping exists at company 
A, there will be a common and fixed language for software quality assurance engineers and 
developers to communicate the test failures.  
 
5.2.1.2 Defect minimisation 
Since company A has very detailed control flow diagrams, mapping each state of the con-
trol flow diagram into SW91 defect categories could minimise the occurrence of defects from 
the implementation phase. When company A has the potential defect categories for every 
state of the control flow diagrams and requirements, developers can work to avoid those 
mapped defect categories during the development. Software quality assurance engineers can 
execute test cases to find those mapped defect categories. Again, this will minimise the time 
to find defects in the application and will help to prevent the defects at the earliest possible 
phase of software development. 
5.2.1.3 Risk minimisation 
Each requirement from the user requirements documentation has associated risks. Using 
the mappings explained in this study, each requirement has been mapped into its potential 
SW91 defect categories. If each requirement can be implemented with the minimum number 
of defects, then it is possible to minimise the associated risks as well. This type of software 
development with mapped SW91 defect categories at company A will help to minimise risks. 
This section explained how an initial investigation was carried out with data from a medi-
cal device software development company and how the applicability of taxonomy based test-
ing was investigated. The applicability of taxonomy based testing to the empirical data from a 
medical device software development company and benefits of taxonomy based testing was 
detailed in this section. Software Process Improvement (SPI) aims to improve  quality and 
productivity levels [39]. Similarly, implementing taxonomy based testing will help to improve 
the quality of the product via achieving the above-stated benefits.   
Section 5.3 presents another validation method of SW91 which is mapping defects from 
open databases.  
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5.3 Mapping Common Weakness Enumeration (CWE) vulnerabili-
ties into SW91 defect categories  
The CWE is an open source list containing common software weaknesses and their vul-
nerabilities. CWE Version 2.9 [40] was the latest version available when the mapping was 
started. CWE Version 2.9 contains 1004 vulnerabilities. This version of the CWE has multiple 
views such as full dictionary view, development view, research view and fault pattern view.  
Prior to the mapping, it was necessary to select the appropriate view of vulnerabilities 
from the CWE. After carefully analysing the multiple views, the cross section view from the 
CWE was mapped into SW91 defect categories. The approach to the mapping and the selec-
tion of the cross section view was discussed and finalised with the SW91 development team. 
The SW91 development team is composed of members from a number of relevant disciplines 
such as medical device product development, software engineering, software quality, and reg-
ulatory policy with members considered expert in their field. 
The cross section view contains a selection of software weaknesses which represent the 
range of weaknesses captured in the CWE. These weaknesses include a total of 158 vulnera-
bilities [40]. From the CWE cross section, out of 158 vulnerabilities, 150 vulnerabilities were 
successfully mapped into SW91 defect categories. This was a manual one to one mapping. In 
the initial mapping, it was not possible to find a suitable category from SW91 for the follow-
ing eight vulnerabilities from the CWE cross section:  
• 173: Improper Handling of Alternate Encoding.  
• 175: Improper Handling of Mixed Encoding.  
• 222: Truncation of Security-relevant Information.  
• 434: Unrestricted Upload of File with Dangerous Type. 
• 323: Reusing a Nonce, Key Pair in Encryption. 
• 486: Comparison of Classes by Name. 
• 502: Deserialization of Untrusted Data. 
• 798: Use of Hard-coded Credentials. 
The one to one mapping was reviewed by the SW91 development team who paid particu-
lar attention to the eight vulnerabilities that could not be mapped. The team members checked 
for the possibility of mapping them into existing SW91 defect categories and there was a dis-
cussion on adding new defect categories and changing the name of a defect category, in order 
to ensure that all vulnerabilities could be mapped into a suitable defect category from SW91.  
Out of the eight vulnerabilities which could not initially be mapped, five vulnerabilities 
were mapped into newly added defect categories or defect categories that required name 
changes. Three vulnerabilities were mapped into an existing defect category. This one to one 
mapping established that all of the CWE cross section vulnerabilities could be mapped to at 
least one defect category from SW91. 
From the completed one to one mapping, a subset of vulnerabilities was selected by an 
experienced team member. The selected subset included eighteen vulnerabilities from all 
phases of the software development lifecycle and one to many mappings were conducted for 
these vulnerabilities. In the one to many mappings, each vulnerability was potentially mapped 
into multiple different defect categories from SW91. The purpose of the one to many mapping 
was to show the usability of SW91. Figure 4 shows an example of a one to many mapping
2
. 
                                                     
2
 This capture is from the draft version of the standard that was out for public comment.  
This is not intended to represent the final version of the standard.   
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In the validation process, out of the eighteen mappings, five mappings were accepted by 
the team without any changes. Three mappings were changed by adding additional defect 
categories into the existing mapping. Two mappings were changed by adding additional de-
fect categories and deleting some mapped categories from the existing mappings. Three map-
pings were changed by adding additional defect categories including the reason for why those 
categories were selected. Two mappings were changed by deleting selected mapped defect 
categories from the existing mappings. One mapping was changed by deleting a defect cate-
gory from existing mapping and including the reason for why other categories were selected. 
Finally, two existing mapping were deleted and replaced with new defect categories from 
SW91.  
For example, vulnerability 642: External Control of Critical State Data was mapped by the 
researcher into the following two defect categories from SW91. The third defect category was 
added by the team members when they were validating the one to many mappings:  
1. Failure to Protect (5.3.2.3.3): Software permits access to an object that should be 
protected (for security reasons rather than for coherency), assuming the design is cor-
rect.  
2. Private Data Declared Public (5.3.1.6.2): An object is declared as public when it 
should be private. The object may be accessible to functions that should not use it, 
creating an unintended dependency or security vulnerability.
 
 
3. Security (3.8): The defects are related to security issues in the architecture, such as 
compromising of sensitive information, choosing an inappropriate authentication pro-
tocol, not using access control, or communication integrity. It may also include the use 
of unsigned software and the introduction of unknown changes after the software is 
deployed. Note that many issues related to security involve requirements inadequacies, 
and many security vulnerabilities might be caused by poor design or implementation 
activities. Capturing all the causes and contributing factors for a security defect should 
involve identifying possible Requirement Defects (2.*), Design Defects (4.*) and Im-
plementation Defects (5.*) rather than categorising every failure associated with secu-
rity as a Security (3.8) defect.  
This one to many mapping shows how a user can select multiple different defect catego-
ries from SW91 to map into a particular vulnerability. This subset of mappings was added as 
annex D in SW91. This CWE mapping was conducted as part of the validation of SW91. This 
work was carried out to determine the defect categories and their coverage in SW91 when 
compared with publicly available vulnerabilities.  
This section detailed the three validation methods for SW91. The next section explains 
how the first track of validation, taxonomy based testing will be implemented at different 
companies in order to improve software quality and to validate SW91.  
6.  Future work 
This paper explains three validation methods for SW91 including a testing approach 
called taxonomy based testing, mapping data from a medical device software development 
company and the CWE mapping. The mapping work with company A was used to conduct a 
retrospective analysis of taxonomy based testing. Another retrospective analysis will be 
performed at a medical device software company, company B in Ireland to further investigate 
taxonomy based testing. The company B retrospective study will be conducted with the fol-
lowing participants: 
1. Quality assurance engineers. 
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2. Developers. 
3. Quality assurance manager. 
Requirements and their identified defects will be collected from a completed project at 
company B. First software quality assurance engineers and developers will be asked to map 
the requirements into the potential SW91 defect categories. Then they will be asked to map 
the defects into SW91 defect categories. An analysis will be conducted on the mapped defect 
categories to investigate taxonomy based testing. The results of the analysis will be used to 
evaluate the following points: 
• The implication of taxonomy based testing at a medical device software development 
company. 
• Comprehensiveness of SW91. 
A protocol has been written for the future implementation of taxonomy based testing. This 
protocol will enable the implementation of taxonomy based testing in any medical device 
software development company. The protocol has the following four phases: 
1. Requirements mapping. 
2. Test case writing. 
3. Test execution. 
4. Results analysis. 
This protocol will be implemented at company C which develops medical device software 
and a software testing company, company D from Ireland. Data from each of the companies 
will be used to evaluate taxonomy based testing and to validate SW91. To continue the 
validation of SW91, this taxonomy based testing will consider the following points in terms 
of the validation of SW91: 
• The efficiency of SW91. 
• The reliability of SW91. 
• Useful analyses enabled by SW91. 
• Defect coverage. 
The next section details the summary and the conclusion of this paper. 
7. Summary and Conclusion 
This paper explained software quality problems in the medical device software industry 
and why quality assurance practices may fail to identify defects. The benefits of defect taxon-
omies were outlined. The necessity for a domain specific defect taxonomy in safety critical 
domains was also briefly explained. The development of a new defect classification for health 
software, SW91, is underway to address this need in the medical device domain. Defect tax-
onomy validation methods were identified. These will be used to validate SW91. As a part of 
the validation of this newly developed defect classification for health software - SW91, two 
mappings were completed. Firstly, a mapping with the CWE’s vulnerabilities and, secondly, 
with data from a medical device software company, company A. These mappings examined 
the reliability and the defect coverage of SW91. The company A mappings were used to 
conduct a retrospective analysis of taxonomy based testing. This paper detailed the applicabil-
ity of taxonomy based testing and it’s benefits. Future work will utilise the taxonomy based 
testing protocol to implement taxonomy based testing at two medical device software devel-
opment companies and a testing company. The results of this implementation will be used to 
assess the benefits of taxonomy based testing and the results will also be used to validate 
SW91 in terms of efficiency, reliability, enabling of useful analyses and defect coverage of 
SW91.  
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Table 1: Medical device software related adverse events [5] 
Device type 
Number of adverse events 
Deaths Injury Malfunction 
Image processing system (LLZ) 1 0 4 
Image-intensified fluoroscopic x-ray 
system (JAA) 
0 1 2186 
Implantable defibrillator (NIK/LWS 
MRM) 
293 14,281 11,028 
Physiological patient monitor/ arrhyth-
mia detector or alarm (MHX/DSI) 
4 79 276 
 
Table 2: Defect taxonomies 
 
Table 3: SW91 defect categories 
Parent level defect categories 
Planning (1) 
Requirements (2) 
Architecture and Design (3) 
Implementation (4) 
Test (5) 
Release Defects (6) 
Maintenance (7) 
Defect Taxonomies Developed By 
Orthogonal defect classification (ODC) scheme IBM 
Hewlett-Packard (HP) defect categorisation scheme Hewlett-Packard company 
IEEE standard classification for software anomalies IEEE standard community 
Taxonomy for software bugs Boris Beizer 
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Figure 2: Modified IEC 62304 V model and taxonomy based testing
Figure 1: Taxonomy Based Testing 
Page 20 of 25
http://mc.manuscriptcentral.com/jsme
Journal of Software: Evolution and Process
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
EuroSPI 2017 − 1.21 
 
Figure 3: Mapping company A's data into SW91 
 
 
 
Figure 4: CWE Mapping
2
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